ArticleFrontiers in immunology2016

Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.

Yamila Sol Rocca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.